NCT00608452View on ClinicalTrials.gov

Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 1995

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Lung CancerOvarian CancerBreast CancerHodgkin's DiseaseNeuroblastoma
Interventions
OTHER

Symptom Assessment Scale

"* Memorial Symptom Assessment Scale~* History and neurologic examination"

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00608452 - Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | Biotech Hunter | Biotech Hunter